Battle of the BPH procedures: which one gets you off the catheter faster?

NCT ID NCT04338776

Ongoing Symptom relief Sponsor: NeoTract, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two minimally invasive procedures for treating an enlarged prostate (BPH) in 120 men aged 50 and older. The goal is to see which treatment—UroLift or Rezūm—leads to fewer catheters, less need for repeat procedures, and lower medication use over 12 months. The main focus is on how quickly patients can urinate without a catheter after treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC HYPERPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BENIGN PROSTATIC HYPERPLASIA

Contacts and locations

Locations

Cambridge University Hospitals NHS Foundation Trust

Cambridge, CB2 0QQ, United Kingdom
Comprehensive Urology

Royal Oak, Michigan, 48073, United States
Frimley Park Hospital

Frimley, Camberley, 6U167UJ UK, United Kingdom
NORFOLK and Norwich University Hospital

Norwich, Norfolk, NR4 7UY, United Kingdom
NYU Winthrop Urology

Garden City, New York, 11530, United States
Tower Urology

Los Angeles, California, 90048, United States
UT Southwestern Medical Center

Dallas, Texas, 75048, United States
Urology Austin

Austin, Texas, 78759, United States
Urology San Antonio

San Antonio, Texas, 78229, United States
Weil Cornell Medical College, Cornell University

New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.